Ondansetron Hydrochloride Injection

[Indications] It is indicated for the prevention of nausea and vomiting associated with emetogenic cancer chemotherapy, including initial and repeat courses of chemotherapy, and for the prevention of postoperative nausea and vomiting.

[Usage and dosage] For the prevention of chemotherapy-induced nausea and vomiting:
Adults and pediatric patients 6 months and older: the recommended dose is 0.15 mg/kg per dose for 3 doses. The first dose should be administered 30 minutes before the start of chemotherapy, followed by additional doses 4 and 8 hours after the first dose. Each dose should be diluted and administered by intravenous infusion over approximately 15 minutes. The maximum single dose is 16 mg.